The history of Viagra presents a complex picture for investors. While the initial release generated massive profits, the expiration of its patent opened the door to off-brand alternatives, dramatically reducing revenue. This poses a unique risk for drug manufacturers banking on similar blockbuster offerings, suggesting that a unquestioning investme

The story of Viagra, and its developer copyright, presents a challenging case study for investors. Originally a blockbuster drug, yielding billions in sales , its exclusivity period created a flood of knock-off medications, significantly eroding its market share . While specific businesses may attempt to capitalize on similar conditions , the exist